A study at The University of Texas MD Anderson Cancer Center discovered a novel therapeutic vulnerability for patients who have
Read more
Home »
Research shows heterogeneity in melanoma tumors prevents effective immune responses
Diversity—at least among cancer cells—is not a good thing. Weizmann Institute of Science research shows that in melanoma, tumors with
Read more
Maintenance therapy with rucaparib shows clinical responses in a subgroup of patients with pancreatic cancer
Maintenance treatment with the PARP inhibitor rucaparib (Rubraca) was well tolerated and provided clinical responses among patients with advanced BRCA-
Read more